STAT Proteins: a Kaleidoscope of Canonical and Non-canonical Functions in Immunity and Cancer
Overview
Oncology
Affiliations
STAT proteins represent an important family of evolutionarily conserved transcription factors that play key roles in diverse biological processes, notably including blood and immune cell development and function. Classically, STAT proteins have been viewed as inducible activators of transcription that mediate cellular responses to extracellular signals, particularly cytokines. In this 'canonical' paradigm, latent STAT proteins become tyrosine phosphorylated following receptor activation, typically via downstream JAK proteins, facilitating their dimerization and translocation into the nucleus where they bind to specific sequences in the regulatory region of target genes to activate transcription. However, growing evidence has challenged this paradigm and identified alternate 'non-canonical' functions, such as transcriptional repression and roles outside the nucleus, with both phosphorylated and unphosphorylated STATs involved. This review provides a revised framework for understanding the diverse kaleidoscope of STAT protein functional modalities. It further discusses the implications of this framework for our understanding of STAT proteins in normal blood and immune cell biology and diseases such as cancer, and also provides an evolutionary context to place the origins of these alternative functional modalities.
STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis.
Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B Bioimpacts. 2025; 15:30030.
PMID: 39963570 PMC: 11830145. DOI: 10.34172/bi.30030.
Multi-Omics and Network-Based Drug Repurposing for Septic Cardiomyopathy.
Liu P, Yu X, Pan Q, Ren J, Han Y, Zhang K Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861106 PMC: 11768530. DOI: 10.3390/ph18010043.
Discovery of 2-Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents.
Siddappa T, Ravish A, Xi Z, Mohan A, Girimanchanaika S, Krishnamurthy N ACS Omega. 2025; 10(1):114-126.
PMID: 39829533 PMC: 11740381. DOI: 10.1021/acsomega.3c10504.
The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain.
Haas-Neill L, Meneksedag-Erol D, Chaudhry A, Novoselova M, Ashraf Q, de Araujo E Protein Sci. 2024; 34(1):e70022.
PMID: 39723827 PMC: 11670306. DOI: 10.1002/pro.70022.
Akula S, Alvarado-Vazquez A, Haide Mendez Enriquez E, Bal G, Franke K, Wernersson S Int J Mol Sci. 2024; 25(23).
PMID: 39684762 PMC: 11642334. DOI: 10.3390/ijms252313050.